C-Reactive Protein Rapid Test Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : November 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC117070

C-Reactive Protein Rapid Test Market by Type (Immunoturbidimetric assay, Chemiluminescence immunoassay, ELISA, Others) Application (Hospitals, Clinics, Laboratories) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The C-reactive protein rapid test market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. A c-receptive protein test measures the level of c-responsive protein (CRP) in your blood. CRP is a protein made by your liver. It's sent into the bloodstream because of inflammation. Inflammation is your body's method for ensuring your tissues in the event that you've been harmed or have an infection. It can cause redness, pain, and swelling in the affected area.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global C-reactive protein rapid test market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • HORIBA Ltd.
  • Merck & Co., Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings
  • Abbott
  • F Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics
  • Quest Diagnostics
  • Danaher

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         C-Reactive Protein Rapid Test Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o    Immunoturbidimetric assay

o    Chemiluminescence immunoassay

o    ELISA

o    Others

·         C-Reactive Protein Rapid Test Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Clinics

o    Laboratories

·         C-Reactive Protein Rapid Test Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    HORIBA Ltd.

o    Merck & Co., Inc.

o    Siemens Healthineers

o    Thermo Fisher Scientific, Inc.

o    Laboratory Corporation of America Holdings

o    Abbott

o    F Hoffmann-La Roche Ltd.

o    Ortho Clinical Diagnostics

o    Quest Diagnostics

o    Danaher

·         C-Reactive Protein Rapid Test Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America C-Reactive Protein Rapid Test Market, By Country

o    U.S. C-Reactive Protein Rapid Test Market

o    Canada C-Reactive Protein Rapid Test Market

o    Mexico C-Reactive Protein Rapid Test Market

o    Europe

§  Europe C-Reactive Protein Rapid Test Market, By Country

o    Germany C-Reactive Protein Rapid Test Market

o    UK C-Reactive Protein Rapid Test Market

o    France C-Reactive Protein Rapid Test Market

o    Russia C-Reactive Protein Rapid Test Market

o    Italy C-Reactive Protein Rapid Test Market

o    Rest of Europe C-Reactive Protein Rapid Test Market

o    Asia-Pacific

§  Asia-Pacific C-Reactive Protein Rapid Test Market, By Country

o    China C-Reactive Protein Rapid Test Market

o    Japan C-Reactive Protein Rapid Test Market

o    South Korea C-Reactive Protein Rapid Test Market

o    India C-Reactive Protein Rapid Test Market

o    Southeast Asia C-Reactive Protein Rapid Test Market

o    Rest of Asia-Pacific C-Reactive Protein Rapid Test Market

o    South America

§  South America C-Reactive Protein Rapid Test Market

o    Brazil C-Reactive Protein Rapid Test Market

o    Argentina C-Reactive Protein Rapid Test Market

o    Columbia C-Reactive Protein Rapid Test Market

o    Rest of South America C-Reactive Protein Rapid Test Market

o    Middle East and Africa

§  Middle East and Africa C-Reactive Protein Rapid Test Market

o    Saudi Arabia C-Reactive Protein Rapid Test Market

o    UAE C-Reactive Protein Rapid Test Market

o    Egypt C-Reactive Protein Rapid Test Market

o    Nigeria C-Reactive Protein Rapid Test Market

o    South Africa C-Reactive Protein Rapid Test Market

o    Rest of MEA C-Reactive Protein Rapid Test Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       C-Reactive Protein Rapid Test Market, By Type

5.1.     Introduction

5.2.     Global C-Reactive Protein Rapid Test Revenue and Market Share by Type (2017-2027)

5.2.1.  Global C-Reactive Protein Rapid Test Revenue and Revenue Share by Type (2017-2027)

5.3.     Immunoturbidimetric assay

5.3.1.  Global Immunoturbidimetric assay Revenue and Growth Rate (2017-2027)

5.4.     Chemiluminescence immunoassay

5.4.1.  Global Chemiluminescence immunoassay Revenue and Growth Rate (2017-2027)

5.5.     ELISA

5.5.1.  Global ELISA Revenue and Growth Rate (2017-2027)

5.6.     Others

5.6.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       C-Reactive Protein Rapid Test Market, By Application

6.1.     Introduction

6.2.     Global C-Reactive Protein Rapid Test Revenue and Market Share by Application (2017-2027)

6.2.1.  Global C-Reactive Protein Rapid Test Revenue and Revenue Share by Application (2017-2027)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.4.     Clinics

6.4.1.  Global Clinics Revenue and Growth Rate (2017-2027)

6.5.     Laboratories

6.5.1.  Global Laboratories Revenue and Growth Rate (2017-2027)

7.       C-Reactive Protein Rapid Test Market, By Region

7.1.     Introduction

7.2.     Global C-Reactive Protein Rapid Test Revenue and Market Share by Regions

7.2.1.  Global C-Reactive Protein Rapid Test Revenue by Regions (2017-2027)

7.3.     North America C-Reactive Protein Rapid Test by Countries

7.3.1.  North America C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2027)

7.3.2.  North America C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe C-Reactive Protein Rapid Test by Countries

7.4.1.  Europe C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2027)

7.4.2.  Europe C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific C-Reactive Protein Rapid Test by Countries

7.5.1.  Asia-Pacific C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America C-Reactive Protein Rapid Test by Countries

7.6.1.  South America C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2027)

7.6.2.  South America C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa C-Reactive Protein Rapid Test by Countries

7.7.1.  Middle East and Africa C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     HORIBA Ltd.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Merck & Co., Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Siemens Healthineers

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Thermo Fisher Scientific, Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Laboratory Corporation of America Holdings

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Abbott

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     F Hoffmann-La Roche Ltd.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Ortho Clinical Diagnostics

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Quest Diagnostics

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Danaher

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.1.     Global C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     C-Reactive Protein Rapid Test Market Forecast by Regions (2017-2027)

9.2.1.  North America C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.1.1.  United States C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.1.2.  Canada C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.1.3.  Mexico C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.  Europe C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.1.  Germany C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.2.  France C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.3.  UK C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.4.  Russia C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.5.  Italy C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.  Asia-Pacific C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.1.  China C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.2.  Japan C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.3.  Korea C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.4.  India C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.4.  South America C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.4.1.  Brazil C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.4.2.  Argentina C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.4.3.  Columbia C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.4.4.  Rest of South America C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.  Middle East and Africa C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.3.  Egypt C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.4.  Nigeria C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.5.  South Africa C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.6.  Turkey C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa C-Reactive Protein Rapid Test Market Forecast (2017-2027)

9.3.     C-Reactive Protein Rapid Test Market Forecast by Type (2017-2027)

9.3.1.  C-Reactive Protein Rapid Test Forecast by Type (2017-2027)

9.3.2.  C-Reactive Protein Rapid Test Market Share Forecast by Type (2017-2027)

9.4.     C-Reactive Protein Rapid Test Market Forecast by Application (2017-2027)

9.4.1.  C-Reactive Protein Rapid Test Forecast by Application (2017-2027)

9.4.2.  C-Reactive Protein Rapid Test Market Share Forecast by Application (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure France C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure China C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure India C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa C-Reactive Protein Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Table Global C-Reactive Protein Rapid Test Revenue and Revenue Share by Type (2017-2018)
Figure Global Immunoturbidimetric assay Revenue and Growth Rate (2017-2018)
Figure Global Chemiluminescence immunoassay Revenue and Growth Rate (2017-2018)
Figure Global ELISA Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global C-Reactive Protein Rapid Test Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Laboratories Revenue and Growth Rate (2017-2018)
Table Global C-Reactive Protein Rapid Test Revenue by Regions (2017-2018)
Figure North America C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure North America C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2018)
Figure North America C-Reactive Protein Rapid Test by Countries (2017-2018)
Figure North America C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure United States C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure United States C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Canada C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Mexico C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Europe C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2018)
Figure Europe C-Reactive Protein Rapid Test by Countries (2017-2018)
Figure Europe C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Germany C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Germany C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure France C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure UK C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Russia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Italy C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Rest of Europe C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Asia-Pacific C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific C-Reactive Protein Rapid Test by Countries (2017-2018)
Figure Asia-Pacific C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure China C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure China C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Japan C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Korea C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure India C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Southeast Asia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Rest of Asia-Pacific C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure South America C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2018)
Figure South America C-Reactive Protein Rapid Test by Countries (2017-2018)
Figure South America C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Brazil C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Brazil C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Argentina C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Columbia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Rest of South America C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Middle East and Africa C-Reactive Protein Rapid Test Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa C-Reactive Protein Rapid Test by Countries (2017-2018)
Figure Middle East and Africa C-Reactive Protein Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Saudi Arabia C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure United Arab Emirates C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Egypt C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Nigeria C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure South Africa C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Turkey C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa C-Reactive Protein Rapid Test Growth Rate (2017-2018)
Figure Rest of Middle East and Africa C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Table HORIBA Ltd. C-Reactive Protein Rapid Test Financial Overview
Table Merck & Co., Inc. C-Reactive Protein Rapid Test Financial Overview
Table Siemens Healthineers C-Reactive Protein Rapid Test Financial Overview
Table Thermo Fisher Scientific, Inc. C-Reactive Protein Rapid Test Financial Overview
Table Laboratory Corporation of America Holdings C-Reactive Protein Rapid Test Financial Overview
Table Abbott C-Reactive Protein Rapid Test Financial Overview
Table F Hoffmann-La Roche Ltd. C-Reactive Protein Rapid Test Financial Overview
Table Ortho Clinical Diagnostics C-Reactive Protein Rapid Test Financial Overview
Table Quest Diagnostics C-Reactive Protein Rapid Test Financial Overview
Table Danaher C-Reactive Protein Rapid Test Financial Overview
Figure Global C-Reactive Protein Rapid Test Revenue (Millions USD) and Growth Rate (2018-2025)
Table C-Reactive Protein Rapid Test Market Forecast by Regions (2018-2025)
Figure North America C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure United States C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Canada C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Mexico C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Europe C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Germany C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure France C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure UK C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Russia C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Italy C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Rest of Europe C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Asia-Pacific C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure China C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Japan C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Korea C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure India C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Southeast Asia C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Rest of Asia-Pacific C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure South America C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Brazil C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Argentina C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Columbia C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Rest of South America C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Middle East and Africa C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Saudi Arabia C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure United Arab Emirates C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Egypt C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Nigeria C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure South Africa C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Turkey C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Rest of Middle East and Africa C-Reactive Protein Rapid Test Market Forecast (2018-2025)
Figure Global C-Reactive Protein Rapid Test Forecast by Type (2018-2025)
Figure Global C-Reactive Protein Rapid Test Market Share Forecast by Type (2018-2025)
Figure Global C-Reactive Protein Rapid Test Forecast by Type (2018-2025)
Figure Global C-Reactive Protein Rapid Test Forecast by Application (2018-2025)
Figure Global C-Reactive Protein Rapid Test Market Share Forecast by Application (2018-2025)
Figure Global C-Reactive Protein Rapid Test Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*